Long-Term Changes of Urinary Exosomal Peptide Levels After Thyroidectomy in Patients with Thyroid Cancer: A Prospective Observational Study
ABSTRACT
The study aimed to investigate the potential of urine exosomal peptide levels to predict the risk of thyroid cancer recurrence after thyroidectomy.
METHODS
Patients newly diagnosed with papillary thyroid cancer and who had undergone thyroidectomy were included. Urine samples were collected at 12 months and 24 months after enrollment, and urine exosomes containing different peptides were analyzed.
RESULTS
70 patients were enrolled, categorized by the time interval between surgery and enrollment. No recurrences were observed during the 2-year follow-up. No significant differences were found in serum proteins or urine exosomal peptides between groups or time intervals. Known risk factors for high-risk thyroid cancer showed only mild correlation with serum protein levels and urine exosomal peptides.
CONCLUSION
The study revealed the long-term fluctuation ranges of serum proteins and urine exosomal peptides in thyroid cancer patients post-thyroidectomy. Concentrations of serum proteins or urine exosomal peptides within certain ranges may indicate a lower risk of thyroid cancer recurrence in high-risk patients.
TRIAL REGISTRATION: ClinicalTrials.gov: NCT03488134.
PMID: 38803995 | PMC: PMC11129743 | DOI: 10.2147/IJN.S458931
Clinical trials are key to developing safe and effective treatments. It’s important to extend their benefits into everyday medical practice. DocSym, our AI-driven platform, helps by consolidating ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians.
In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.
By using AI, clinics can enhance their workflows and improve patient outcomes, reduce paper routine. Learn more about how we can help at aidevmd.com.